Tofacitinib Treatment Is Associated With Modest and Reversible Increases in Serum Lipids in Patients With Ulcerative Colitis-Reference-Cited by-同舟云学术

Tofacitinib Treatment Is Associated With Modest and Reversible Increases in Serum Lipids in Patients With Ulcerative Colitis

Published:2020-01 Issue:1 Volume:18 Page:123-132.e3
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Sands Bruce E.,Taub Pam R.,Armuzzi Alessandro,Friedman Gary S.,Moscariello Michele,Lawendy Nervin,Pedersen Ronald D.,Chan Gary,Nduaka Chudy I.,Quirk Daniel,Salese Leonardo,Su Chinyu,Feagan Brian G.

Funder

Pfizer Inc

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference25 articles.

1. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) * Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)

2. Inflammatory bowel disease and risk of coronary heart disease;Rungoe;Trends Cardiovasc Med,2015

3. Comprehensive nutritional status in recently diagnosed patients with inflammatory bowel disease compared with population controls;Geerling;Eur J Clin Nutr,2000

4. Comprehensive study of cardiovascular morbidity in hospitalized inflammatory bowel disease patients;Sridhar;J Crohns Colitis,2011

5. Risk of cerebrovascular accidents and ischemic heart disease in patients with inflammatory bowel disease: a systematic review and meta-analysis;Singh;Clin Gastroenterol Hepatol,2014

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Small Molecule Therapy for Inflammatory Bowel Disease: JAK Inhibitors and S1PR Modulators;The Korean Journal of Gastroenterology;2024-08-25

2. Preventing and managing cardiovascular events in patients with inflammatory bowel diseases treated with small-molecule drugs, an international Delphi consensus;Digestive and Liver Disease;2024-08

3. Real-world efficacy and safety of tofacitinib treatment in Asian patients with ulcerative colitis;World Journal of Gastroenterology;2024-04-07

4. Managing Risks with Newer Oral Small Molecules in Patients with Inflammatory Bowel Diseases;Current Gastroenterology Reports;2024-02-14

5. The role of filgotinib in ulcerative colitis and Crohn’s disease;Immunotherapy;2024-02